Skretting G - Search Results

1

Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.

Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sandset PM. Opstad TB, et al. Among authors: skretting g. Blood Coagul Fibrinolysis. 2010 Sep;21(6):516-21. doi: 10.1097/MBC.0b013e32833a06cd. Blood Coagul Fibrinolysis. 2010. PMID: 20453636

2

A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.

Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM. Dahm AE, et al. Among authors: skretting g. Thromb Res. 2012 Jul;130(1):45-51. doi: 10.1016/j.thromres.2011.12.009. Epub 2012 Jan 2. Thromb Res. 2012. PMID: 22217510 Clinical Trial.

3

Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis.

Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM. Dahm AE, et al. Among authors: skretting g. Br J Haematol. 2012 Jun;157(6):753-61. doi: 10.1111/j.1365-2141.2012.09121.x. Epub 2012 Apr 26. Br J Haematol. 2012. PMID: 22533697 Free article. Clinical Trial.

4

Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability.

Skretting G, Lien T, Sandset PM, Iversen N. Skretting G, et al. Thromb Res. 2009 Apr;123(6):851-5. doi: 10.1016/j.thromres.2008.09.003. Epub 2008 Nov 13. Thromb Res. 2009. PMID: 19007969

5

Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis.

Tjeldhorn L, Sandset PM, Haugbro K, Skretting G. Tjeldhorn L, et al. Among authors: skretting g. Thromb Res. 2010 Mar;125(3):230-4. doi: 10.1016/j.thromres.2009.05.013. Epub 2009 Jun 17. Thromb Res. 2010. PMID: 19535131

6

Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis.

Dahm AE, Tiscia G, Holmgren A, Jacobsen AF, Skretting G, Grandone E, Sandset PM. Dahm AE, et al. Among authors: skretting g. J Thromb Haemost. 2015 Mar;13(3):409-13. doi: 10.1111/jth.12817. Epub 2015 Jan 19. J Thromb Haemost. 2015. PMID: 25495894 Free article.

7

Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.

Cui XY, Tinholt M, Stavik B, Dahm AE, Kanse S, Jin Y, Seidl S, Sahlberg KK, Iversen N, Skretting G, Sandset PM. Cui XY, et al. Among authors: skretting g. J Thromb Haemost. 2016 Feb;14(2):387-96. doi: 10.1111/jth.13206. Epub 2016 Jan 30. J Thromb Haemost. 2016. PMID: 26598923 Free article.

8

Overexpression of both TFPIα and TFPIβ induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells.

Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N. Stavik B, et al. Among authors: skretting g. Mol Carcinog. 2010 Nov;49(11):951-63. doi: 10.1002/mc.20679. Mol Carcinog. 2010. PMID: 20886581

9

Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-κB and apoptosis mediated by a caspase-3 independent pathway.

Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM. Skretting G, et al. Mol Biol Rep. 2012 Dec;39(12):10089-96. doi: 10.1007/s11033-012-1882-7. Epub 2012 Aug 30. Mol Biol Rep. 2012. PMID: 22932941

10

Oestrogen induced downregulation of TFPI expression is mediated by ERα.

Ali HO, Stavik B, Dørum E, Iversen N, Sandset PM, Skretting G. Ali HO, et al. Among authors: skretting g. Thromb Res. 2014 Jul;134(1):138-43. doi: 10.1016/j.thromres.2014.04.004. Epub 2014 Apr 13. Thromb Res. 2014. PMID: 24785473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page